PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 66 filers reported holding PAIN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $156,000 | +56.0% | 175,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $100,000 | -37.5% | 175,000 | +9.4% | 0.00% | 0.0% |
Q3 2016 | $160,000 | -54.3% | 160,000 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $350,000 | -2.0% | 160,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $357,000 | +27.5% | 160,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $280,000 | -4.4% | 160,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $293,000 | +2.8% | 160,000 | -3.0% | 0.00% | +100.0% |
Q2 2015 | $285,000 | -8.7% | 165,000 | 0.0% | 0.00% | -50.0% |
Q1 2015 | $312,000 | -12.1% | 165,000 | -5.7% | 0.00% | 0.0% |
Q4 2014 | $355,000 | -49.6% | 175,000 | -2.8% | 0.00% | -50.0% |
Q3 2014 | $704,000 | -53.8% | 180,000 | -32.1% | 0.00% | -50.0% |
Q2 2014 | $1,524,000 | -2.8% | 265,000 | -7.0% | 0.01% | 0.0% |
Q1 2014 | $1,568,000 | +7.5% | 285,000 | -5.0% | 0.01% | 0.0% |
Q4 2013 | $1,458,000 | +50.9% | 300,000 | -15.5% | 0.01% | +60.0% |
Q3 2013 | $966,000 | +15.0% | 355,000 | -6.6% | 0.01% | 0.0% |
Q2 2013 | $840,000 | – | 380,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |